Sprint Bioscience AB (SPRINT) — Cash Flow Reinvestment Rate
Sprint Bioscience AB (SPRINT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting Skr105.00K (capex Skr65.00K plus investments Skr40.00K) from operating cash flow of Skr115.84 Million. Explore SPRINT capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sprint Bioscience AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Sprint Bioscience AB across 4 annual periods. Also explore balance sheet size of Sprint Bioscience AB for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sprint Bioscience AB (2015–2025)
Year-by-year capital reinvestment analysis for Sprint Bioscience AB. For live market cap and broader valuation context, see SPRINT market cap.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr134.00K | Skr83.53 Million | Skr94.00K | ▼ -99.3% |
| 2023 | 0.21x | Skr4.91 Million | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 2.50x | Skr19.82 Million | Skr7.93 Million | Skr9.91 Million | ▼ -66.4% |
| 2015 | 7.43x | Skr6.19 Million | Skr833.54K | Skr6.19 Million | — |